Prenetics’ IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services
Prenetics' IM8 has launched a groundbreaking space experiment aboard the International Space Station (ISS) in collaboration with the University of Oxford, supported by Space Applications Services. The mission, launched via SpaceX CRS-31 on November 4th, aims to study accelerated aging and longevity using microgravity's unique environment.
The experiment focuses on autophagy, the cellular process of removing and recycling damaged components, using 3D organoids in a specially designed science cube. The research leverages microgravity's ability to accelerate aging processes, potentially leading to insights for improving human healthspan and astronaut health.
Coinciding with this research, IM8 officially launched its premium supplements brand on November 18th on IM8health.com, offering two products: Daily Ultimate Essentials and Daily Ultimate Longevity, now shipping to 31 countries.
IM8 di Prenetics ha avviato un rivoluzionario esperimento spaziale a bordo della Stazione Spaziale Internazionale (ISS) in collaborazione con l'Università di Oxford, supportato da Space Applications Services. La missione, lanciata tramite SpaceX CRS-31 il 4 novembre, ha l'obiettivo di studiare l'invecchiamento accelerato e la longevità sfruttando l'unico ambiente della microgravità.
L'esperimento si concentra sull'autofagia, il processo cellulare di rimozione e riciclo dei componenti danneggiati, utilizzando organoidi 3D in un cubo scientifico appositamente progettato. La ricerca sfrutta la capacità della microgravità di accelerare i processi di invecchiamento, portando potenzialmente a nuove intuizioni per migliorare la durata della salute umana e la salute degli astronauti.
In concomitanza con questa ricerca, IM8 ha ufficialmente lanciato il suo marchio di integratori premium il 18 novembre su IM8health.com, offrendo due prodotti: Daily Ultimate Essentials e Daily Ultimate Longevity, ora disponibili per la spedizione in 31 paesi.
IM8 de Prenetics ha lanzado un experimento espacial innovador a bordo de la Estación Espacial Internacional (ISS) en colaboración con la Universidad de Oxford, apoyado por Space Applications Services. La misión, lanzada a través de SpaceX CRS-31 el 4 de noviembre, tiene como objetivo estudiar el envejecimiento acelerado y la longevidad utilizando el entorno único de microgravedad.
El experimento se centra en la autofagia, el proceso celular de eliminación y reciclaje de componentes dañados, utilizando organoides 3D en un cubo científico especialmente diseñado. La investigación aprovecha la capacidad de la microgravedad para acelerar los procesos de envejecimiento, lo que podría dar lugar a nuevos conocimientos para mejorar la duración de la salud humana y la salud de los astronautas.
Coincidiendo con esta investigación, IM8 lanzó oficialmente su marca de suplementos premium el 18 de noviembre en IM8health.com, ofreciendo dos productos: Daily Ultimate Essentials y Daily Ultimate Longevity, que ahora se envían a 31 países.
프레네틱스의 IM8은 옥스포드 대학교와 협력하여 우주 애플리케이션 서비스의 지원을 받아 국제 우주 정거장(ISS)에서 혁신적인 우주 실험을 시작했습니다. 11월 4일 스페이스X CRS-31을 통해 발사된 이 임무는 미세 중력의 독특한 환경을 활용하여 가속화된 노화와 장수에 대해 연구하는 것을 목표로 합니다.
이 실험은 손상된 성분을 제거하고 재활용하는 세포 과정인 자기 포식에 초점을 맞추고 있으며, 특별히 설계된 과학 큐브에서 3D 오르가노이드를 사용합니다. 이 연구는 미세 중력이 노화 과정을 가속화할 수 있는 능력을 활용하여 인류 건강 지속 기간 향상 및 우주 비행사 건강 개선을 위한 통찰력을 줄 수 있는 가능성이 있습니다.
이 연구와 동시에 IM8은 11월 18일 IM8health.com에서 프리미엄 보충제 브랜드를 공식 출시하였으며, 현재 31개국으로 배가 가능한 두 가지 제품: Daily Ultimate Essentials와 Daily Ultimate Longevity를 제공합니다.
IM8 de Prenetics a lancé une expérience spatiale révolutionnaire à bord de la Station Spatiale Internationale (ISS) en collaboration avec l'Université d'Oxford, soutenue par Space Applications Services. La mission, lancée par SpaceX CRS-31 le 4 novembre, vise à étudier le vieillissement accéléré et la longévité en utilisant l'environnement unique de la microgravité.
Cette expérience se concentre sur l'autophagie, le processus cellulaire d'élimination et de recyclage des composants endommagés, utilisant des organoïdes 3D dans un cube scientifique spécialement conçu. La recherche exploite la capacité de la microgravité à accélérer les processus de vieillissement, ce qui pourrait mener à des aperçus pour améliorer la durée de vie de la santé humaine et la santé des astronautes.
En parallèle de cette recherche, IM8 a officiellement lancé sa marque de compléments alimentaires premium le 18 novembre sur IM8health.com, offrant deux produits : Daily Ultimate Essentials et Daily Ultimate Longevity, maintenant expédiés vers 31 pays.
IM8 von Prenetics hat ein bahnbrechendes Raumexperiment an Bord der Internationalen Raumstation (ISS) in Zusammenarbeit mit der Universität Oxford gestartet, unterstützt von Space Applications Services. Die Mission, die am 4. November über SpaceX CRS-31 gestartet wurde, zielt darauf ab, beschleunigtes Altern und Langlebigkeit unter Nutzung der einzigartigen Umgebung der Mikrogravitation zu untersuchen.
Das Experiment konzentriert sich auf die Autophagie, den zellulären Prozess zur Beseitigung und zum Recycling beschädigter Komponenten, unter Verwendung von 3D-Organoiden in einem speziell entwickelten wissenschaftlichen Würfel. Die Forschung nutzt die Fähigkeit der Mikrogravitation, die Alterungsprozesse zu beschleunigen, was potenziell zu Erkenntnissen führen könnte, die die Gesundheitsspanne des Menschen und die Gesundheit der Astronauten verbessern.
Im Einklang mit dieser Forschung hat IM8 am 18. November offiziell seine Premium-Nahrungsergänzungsmittelmarke auf IM8health.com eingeführt und bietet zwei Produkte an: Daily Ultimate Essentials und Daily Ultimate Longevity, die jetzt an 31 Länder versendet werden.
- Launch of innovative space research program with prestigious partners (University of Oxford, SpaceX)
- Global market reach with products shipping to 31 countries
- Real-time monitoring capabilities of the experiment through ICE Cubes Facility
- None.
Insights
This ISS experiment represents a significant scientific endeavor in aging research, utilizing microgravity conditions to accelerate cellular aging processes. The focus on autophagy - a critical cellular maintenance mechanism - is particularly noteworthy. The use of 3D organoids provides a sophisticated model for studying human tissue responses in space, potentially yielding insights into age-related diseases and interventions.
However, from an investment perspective, while scientifically interesting, this is an early-stage research project with no immediate revenue impact. The actual commercial applications and product development possibilities remain speculative and likely years away from materialization. The concurrent launch of IM8's supplement products, while promising, is not directly connected to the space research outcomes.
The launch of IM8's premium supplement line across 31 countries represents the more immediate business impact. The global supplements market has been experiencing robust growth, particularly in the longevity and healthy aging segments. However, the
While the space research collaboration with Oxford adds scientific credibility to the brand, it's primarily a marketing advantage rather than a near-term financial driver. The supplement launch's success will depend more on market penetration, pricing strategy and consumer acceptance than the ongoing space research.
- Mission Launched via SpaceX CRS-31; Experiment Now Underway on the ISS
- Collaboration Aims to Enhance Healthspan on Earth and Improve Astronaut Health in Space
- IM8, a new premium supplements brand launched officially on November 18th on IM8health.com
CHARLOTTE, N.C., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Prenetics’ IM8 is excited to announce that its groundbreaking month-long space experiment, in partnership with the University of Oxford and supported by Space Applications Services and Metavisionaries, is now underway aboard the International Space Station (ISS). Launched via SpaceX CRS-31 on November 4th at 9:29 pm EST, the mission aims to study accelerated aging and longevity by leveraging microgravity's unique environment to accelerate aging processes at the cellular level.
Dr. Jim Green, former Chief Scientist of NASA and a key member of IM8’s Scientific Advisory Board said, "Space exploration has a remarkable history of leading to significant medical breakthroughs that benefit humanity. For example, research on bone density loss in astronauts has advanced our understanding and treatment of osteoporosis on Earth. Additionally, microgravity has facilitated the growth of high-quality protein crystals, aiding in the development of more effective drugs for conditions such as cancer and diabetes. By investigating accelerated aging in space, we have the potential to uncover new insights into cellular processes that could lead to groundbreaking interventions for age-related diseases."
Microgravity Provides Accelerated Aging Model for Groundbreaking Autophagy Research
Microgravity offers a unique opportunity to study aging processes more rapidly than on Earth. The absence of Earth's gravity affects human physiology in ways that mimic the aging process, including cell degeneration, oxidative stress, and DNA damage. This mission utilizes this phenomenon to investigate the cellular mechanisms behind aging and explore potential interventions.
The experiment focuses on autophagy, the process by which cells remove and recycle damaged components. Autophagy declines with age, contributing to cellular aging and associated health issues such as decreased immune function and chronic inflammation. By enhancing autophagy, it may be possible to mitigate these effects and improve overall healthspan.
Aims to Enhance Healthspan on Earth and Improve Astronaut Health in Space
The mission involves sending specially designed 3D organoids—miniature, simplified versions of human tissues—into space.
Dr. Ghada Alsaleh, Director of the Space Innovation Lab at the University of Oxford, highlighted the study's significance: “Microgravity might provide an accelerated aging model, allowing us to study cellular processes within a compressed timeframe. Our research aims to understand aging pathways in space to help us better moderate and manage aging processes on Earth, as well as explore whether enhancing autophagy can mitigate cellular aging. This work could have profound implications for improving healthspan on Earth and protecting astronaut health during space missions.”
This mission utilizes a specially designed science cube to house the CRT8 ingredients for a full month aboard the ISS. The cube is accommodated inside the ICE Cubes Facility once onboard; this platform provides power and data to the payload, as well as real-time connectivity with ground control. This setup enables researchers back in Oxford to monitor and interact with the experiment in real-time.
"Our collaboration with the University of Oxford represents an important milestone in our commitment to advancing health science," said Danny Yeung, CEO of Prenetics / IM8. "By studying accelerated aging in microgravity, we aim to unlock new insights into cellular health that could enhance healthspan on Earth and improve astronaut health in space."
The findings from this pioneering study are expected to benefit IM8's future endeavors:
- Enhanced Product Efficacy: Understanding how CRT8 ingredients influence autophagy in an accelerated aging model allows us to optimize our supplements for maximum effectiveness in supporting healthspan and longevity.
- Innovation and New Product Development: Discoveries from the study may lead to the creation of new supplements targeting specific aging pathways, reinforcing IM8's position at the forefront of wellness innovation.
IM8 Launched Officially on November 18th on IM8health.com
As part of its commitment to advancing health and longevity, IM8 unveiled its line of premium, science-backed supplement solutions on November 18th at IM8health.com. Now shipping to 31 countries and regions, IM8 introduces two groundbreaking products—Daily Ultimate Essentials and Daily Ultimate Longevity—designed to support optimal daily nutrition and promote healthy aging, backed by clinical trials and third-party testing.
ABOUT PRENETICS
Prenetics (NASDAQ:PRE), a leading health sciences company, is dedicated to advancing consumer and clinical health. Our consumer initiative is led by IM8, a new health and wellness brand and Europa, the largest sports distribution company in the USA. Our clinical division is led by Insighta, our
ABOUT SPACE APPLICATIONS SERVICES
Space Applications Services (SpaceApps) is an independent Belgian company founded in 1987, with offices in Europe (Belgium and the Netherlands) and a subsidiary, Aerospace Applications North America, in Houston, Texas (USA). With a strong focus on R&D, the company collaborates with global partners to develop innovative products, systems and solutions, while providing services to the aerospace and security markets and related industries. The company’s expertise spans various segments, including robotics and AI, flight and ground systems, crewed and autonomous spacecraft, mission control centres and information systems, payload integration and operations.
Through the ICE Cubes Service, SpaceApps provides fast, direct and affordable access to space for research, technology and education, on a commercial basis. The end-to-end service facilitates a frequent and regular ‘launch-and-return’ capability to/from the International Space Station, and offers a unique real-time interaction capability. To date, over 30 payloads, devices and experiments have been successfully flown to the ISS, and operated on board the station. Key markets include health and life sciences, materials, agrifood, and technology.
ABOUT METAVISIONARIES
Metavisionaries is a space and frontier technology company that is dedicated to advancing education, empowering the next generation of pioneers, and making space research and technology accessible to all. Founded by visionary leaders and former NASA scientists, Metavisionaries is dedicated to democratizing access to space research and fostering global innovation. Through our joint venture with Space Application Services, Metaspace, we provide direct access to frontier technologies and the International Space Station to industry, academia and the wider community.
Our goal is not only to inspire and educate, but to equip students, professionals and organisations with practical skills and knowledge that can be directly applied to their future careers and industries.
Investor Relations Contact:
Shannon Devine
MZ North America
shannon.devine@mzgroup.us
(203) 741-8811
Angela Cheung
Investor Relations / Corporate Finance
Prenetics Global Limited
angela.hm.cheung@prenetics.com
FAQ
When did SpaceX launch Prenetics' IM8 space experiment to the ISS?
What is the main purpose of IM8's ISS experiment?
When did IM8 officially launch its supplement products?
What products did IM8 launch in their supplement line?
